Korean Market
OWNR
KOREA PHARMA
★

Eunhee Park and Special Relations Reduce Pledged Shares by 1.46%p via Loan Repayment… No Change in Control

 
EXCH
KOREA PHARMA
★

KOREA PHARMA acquires 18 billion won worth of convertible bonds before maturity, reducing potential dilution risk and improving financial structure

 
EXCH
KOREA PHARMA
★★

KOREA PHARMA Completes 15B KRW 5th Convertible Bond Issuance... Conversion Price (10,782 KRW) Above Current Price (10,030 KRW), Capping Near-Term Dilution Risk but Long-Term Overhang Remains

 
MATR
KOREA PHARMA
★

Decision to Issue KRW 15 Billion Unsecured Private Convertible Bonds - Conversion Price KRW 10,782 (2.8% Premium to Current Price), Potential Dilution 11.31%

 
OWNR
KOREA PHARMA
★

Large Shareholding Report Template – No Substantive Information

 
PERI
KOREA PHARMA
★★

Q1 2026 Operating Profit Turns Positive, Dividend of 50 Won Per Share Maintained